These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3127585)
21. Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial. Giannini EH; Barron KS; Spencer CH; Person DA; Baum J; Bernstein BH; Kredich DW; Jacobs JC; Zemel LS; Gibbas D J Rheumatol; 1991 Aug; 18(8):1240-2. PubMed ID: 1941832 [TBL] [Abstract][Full Text] [Related]
22. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488 [TBL] [Abstract][Full Text] [Related]
23. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis? Bandilla K; Missler B; Klein-Reesink B Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777 [TBL] [Abstract][Full Text] [Related]
24. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin. Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482 [TBL] [Abstract][Full Text] [Related]
25. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: results of a randomized controlled clinical trial. Bulthuis Y; Mohammad S; Braakman-Jansen LM; Drossaers-Bakker KW; van de Laar MA Arthritis Rheum; 2008 Feb; 59(2):247-54. PubMed ID: 18240191 [TBL] [Abstract][Full Text] [Related]
27. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
29. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. Borg G; Allander E; Berg E; Brodin U; From A; Trang L J Rheumatol; 1991 Jul; 18(7):1015-20. PubMed ID: 1920306 [TBL] [Abstract][Full Text] [Related]
30. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures. Morgan GJ Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681 [TBL] [Abstract][Full Text] [Related]
31. [Auranofin in the treatment of rheumatoid arthritis: a multicenter double-blind prospective clinical trial]. Yang JL Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):486-8. PubMed ID: 8275829 [No Abstract] [Full Text] [Related]
32. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis. Carette S; Calin A; McCafferty JP; Wallin BA Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874 [TBL] [Abstract][Full Text] [Related]
34. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments. Johnsen V; Borg G; Trang LE; Berg E; Brodin U Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083 [TBL] [Abstract][Full Text] [Related]
35. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Vischer TL Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924 [TBL] [Abstract][Full Text] [Related]
36. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804 [TBL] [Abstract][Full Text] [Related]
37. Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis. Glennås A; Kvien TK; Andrup O; Clarke-Jenssen O; Karstensen B; Brodin U Br J Rheumatol; 1997 Aug; 36(8):870-7. PubMed ID: 9291856 [TBL] [Abstract][Full Text] [Related]
38. [A multi-center double blind prospective study of ridaura in the treatment of rheumatoid arthritis]. Zhang NZ Zhonghua Nei Ke Za Zhi; 1992 Jul; 31(7):394-7, 443. PubMed ID: 1298591 [TBL] [Abstract][Full Text] [Related]
39. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group. Bombardier C; Raboud J Control Clin Trials; 1991 Aug; 12(4 Suppl):243S-256S. PubMed ID: 1663860 [TBL] [Abstract][Full Text] [Related]
40. [Auranofin in the treatment of rheumatoid arthritis. Report of 63 cases]. Tao XL; Dong Y; Zhang NZ Zhonghua Nei Ke Za Zhi; 1987 Jul; 26(7):390-3, 444. PubMed ID: 3428027 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]